Inventor · disambiguated record
Guaili Wu
Also filed as: WU GUAILI
15 granted patents·2 pending applications·31 citations·filing 2013–2020
89Inventor score
Files withJIANGSU HENGRUI MEDICINE CO17
Top patents by PatentIndex Score
17 records- 0189US10160759B2Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Dec 25, 2018·4 cites·17 claims
- 0289US10023577B2Crystalline form of JAK kinase inhibitor bisulfate and a preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Jul 17, 2018·6 cites·19 claims
- 0385US9422300B2Bisulfate of janus kinase (JAK) inhibitor and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2014·Granted Aug 23, 2016·9 cites·9 claims
- 0483US10150770B2Crystal form of bisulfate of JAK inhibitor and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Dec 11, 2018·6 cites·17 claims
- 0577US10358424B2Sodium salt of uric acid transporter inhibitor and crystalline form thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Jul 23, 2019·1 cites·6 claims
- 0676US9309226B2Crystalline form I of tyrosine kinase inhibitor dimaleate and preparation methods thereofJIANGSU HENGRUI MEDICINE CO·Filed 2013·Granted Apr 12, 2016·3 cites·14 claims
- 0775US10626116B2Crystalline form of BTK kinase inhibitor and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Apr 21, 2020·2 cites·11 claims
- 0863US11198683B2Method for preparing tyrosine kinase inhibitor and derivative thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Dec 14, 2021·0 cites·5 claims
- 0955US10196361B2Sodium salt of uric acid transporter inhibitor and crystalline form thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Feb 5, 2019·0 cites·18 claims
- 1053US10793548B2Method for preparing tyrosine kinase inhibitor and derivative thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Oct 6, 2020·0 cites·7 claims
- 1152US11059810B2Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitorJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Jul 13, 2021·0 cites·6 claims
- 1252US10118911B2P-toluenesulfonate for MEK kinase inhibitor, and crystal form thereof and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Nov 6, 2018·0 cites·18 claims
- 1348US10030018B2Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Jul 24, 2018·0 cites·15 claims
- 1446US10150739B2Crystalline form of androgen receptor inhibitor and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Dec 11, 2018·0 cites·16 claims
- 1546US2018370948A1P-toluenesulfonate for mek kinase inhibitor, method of preparation thereof, and method of use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
- 1642US10301344B2L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereofJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted May 28, 2019·0 cites·17 claims
- 1742US2020347039A1Crystal form of renal outer medullary potassium channel inhibitor and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →